Barclays Downgrades Universal Health Services (UHS) to Equalweight
Barclays analyst Andrew Mok downgraded Universal Health Services (NYSE: UHS) from Overweight to Equalweight with a price target of $179.00.
The analyst comments "We downgrade our previously OW-rated stocks HCA and UHS to EW, and move CYH to UW as we await greater clarity on volumes, payor mix, and Medicaid cuts (more below). Notably, we maintain our OW rating on THC, our preferred hospital name, supported by more conservative 2026 guidance, stronger core earnings growth, and a business mix that is more insulated from upcoming regulatory headwinds. Since June lows, HCA, UHS, and CYH have rebounded 17%, 13%, and 38%, respectively (vs. +1% S&P), providing a window for investors to take profits ahead of 2Q earnings and an uncertain 2027+ outlook."
For an analyst ratings summary and ratings history on Universal Health Services click here. For more ratings news on Universal Health Services click here.
Shares of Universal Health Services closed at $161.26 yesterday.